Mastering Immunity Europe 2021


Understand and manage immune responses in any setting



Thursday 25 March, 2021

9:00am GMT / 10:00am CET


Register Today

As targeted immune therapies grow in complexity, understanding and characterizing immune responses has never been more important. Join us at Mastering Immunity Europe 2021 to learn the latest developments in this evolving field. This meeting is a forum to share knowledge, perspectives and discuss solutions to the complex challenges of immunity following the delivery of biologics and other therapies.

Learn from academic and commercial experts as they highlight their discoveries in the context of both desired (in immuno-oncology and vaccines) and unwanted immune responses (i.e. immunogenicity to biotherapeutics or viral vectors). Share information with like-minded scientists from other organizations and explore new opportunities for collaboration. Discover fresh perspectives and novel ideas to combat the challenges in the rapidly changing field of immunology.


2021 Programme

Time GMTSpeakerTitle
09:00amWELCOME
09:10amDr. Amy Flaxman,
University of Oxford		Antibody responses to viral-vectored coronavirus vaccines
09:35amDr. Tom Henley,
Empyrean Therapeutics		COVID-19 and Potential Future Pandemics: Virus Induced Lymphocytes (VIL)
10:00amDr. Alethea Cope,
IAVI		Developing Vaccines and Therapeutics for Emerging Infectious Diseases
10:25amNETWORKING BREAKOUT ROOMS
11:00amProf. Daniel Olive
IBiSA Cancer Immunomonitoring Platform		Liquid Biopsy using K-Cytof demonstrates a role for Vg9Vd2 T cells as prognostic factor in breast cancer
11:25amMr. Edmund Neo,
ProImmune		Clinical Immune Monitoring in Gene Therapy, Immuno-Oncology and SARS-CoV-2 Programs
11:50amDr. Cynthia Kramer,
Leiden University		Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR
12:25pmBREAK FOR LUNCH
13:30pmDr. Jeremy Fry,
ProImmune		An integrated approach to managing immunogenicity risk and drug immune modulation
13:55pmDr. Zuben Sauna,
FDA		Understanding and navigating the immune responses to CRISPR-associated nuclease Cas9
14:20pmDr. Geoff Hale,
mAbsolve
Characterisation of novel antibodies which are completely silenced with respect to Fc
14:45pmNETWORKING BREAKOUT ROOMS
15:10pmDr. Derek Doherty,
Trinity College Dublin		CD1d-restricted T cells in patients with oesophageal cancer
15:35pmDr. Quirin Hammer,
Karolinska Institute		HLA-E-restricted peptides control natural killer cell responses
16:00pmMeeting Close


Mastering Immunity At a Glance

See highlights and feedback from speakers and attendees from Mastering Immunity Europe



Speakers from previous years

Presentations from our meetings are available online free of charge.

Dr. Lea Bartsch,
Massachusetts General Hospital		Dr. Inderpal Singh,
TEVA Pharmaceuticals		Dr. Zuben Sauna,
FDA		Prof. Tao Dong,
University of Oxford
Prof. Arlene Sharpe,
Harvard University		Dr. Laurent Malherbe, Eli LillyDr. David Wraith,
Apitope		Dr. Priya Sriraman, Celgene
Dr. Vibha Jawa,
Merck		Dr. Rodd Polsky,
GSK		Prof. Farzin Farzeneh,
Kings College London		Dr. Nina Le Bert
Duke NUS
Dr. Tim Hickling,
Roche		Prof. Beatriz Carreno,
University of Pennsylvania		Dr. Jochem Gokemeijer,
Bristol-Myers Squibb		Dr. Sophie Tourdot,
Pfizer


How will I benefit?

  • Be informed of the latest
    strategies for preclinical and clinical immune modulation
  • Quality by Design in drug
    development
  • Case Studies
  • Learn the key issues facing
    drug developers

Conference Enquiries:

Email: enquiries@proimmune.com

Telephone (toll free): USA & Canada +1 888 505 7765

© Copyright ProImmune Ltd. 2001-2024. All Rights Reserved